DK217286D0 - Materialer til fremstilling af mikropartikler indeholdende et biologisk aktivt stof - Google Patents

Materialer til fremstilling af mikropartikler indeholdende et biologisk aktivt stof

Info

Publication number
DK217286D0
DK217286D0 DK217286A DK217286A DK217286D0 DK 217286 D0 DK217286 D0 DK 217286D0 DK 217286 A DK217286 A DK 217286A DK 217286 A DK217286 A DK 217286A DK 217286 D0 DK217286 D0 DK 217286D0
Authority
DK
Denmark
Prior art keywords
active substance
biologically active
materials
microparticles containing
polymers
Prior art date
Application number
DK217286A
Other languages
English (en)
Other versions
DK217286A (da
Inventor
Jehan-Yves Drouin
Michel Veillard
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of DK217286D0 publication Critical patent/DK217286D0/da
Publication of DK217286A publication Critical patent/DK217286A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
DK217286A 1985-05-09 1986-05-09 Materialer til fremstilling af mikropartikler indeholdende et biologisk aktivt stof DK217286A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8507013A FR2581541B1 (fr) 1985-05-09 1985-05-09 Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation

Publications (2)

Publication Number Publication Date
DK217286D0 true DK217286D0 (da) 1986-05-09
DK217286A DK217286A (da) 1986-11-10

Family

ID=9319093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK217286A DK217286A (da) 1985-05-09 1986-05-09 Materialer til fremstilling af mikropartikler indeholdende et biologisk aktivt stof

Country Status (14)

Country Link
EP (1) EP0204596B1 (da)
JP (1) JPS61260029A (da)
KR (1) KR860008774A (da)
AT (1) ATE45283T1 (da)
AU (1) AU579012B2 (da)
CA (1) CA1266841A (da)
DE (1) DE3664867D1 (da)
DK (1) DK217286A (da)
ES (1) ES8802206A1 (da)
FI (1) FI861923A (da)
FR (1) FR2581541B1 (da)
MA (1) MA20670A1 (da)
NZ (1) NZ216082A (da)
ZA (1) ZA863431B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198226A (en) * 1986-01-30 1993-03-30 Syntex (U.S.A.) Inc. Long acting nicardipine hydrochloride formulation
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
FR2634376B1 (fr) 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
FR2663818B1 (fr) * 1990-06-29 1993-07-09 Rhone Poulenc Nutrition Animale Procede de preparation de granules de principes actifs par extrusion.
DE4021678C2 (de) * 1990-07-07 1994-07-07 Merz & Co Gmbh & Co Verfahren zur Herstellung klein dimensionierter Formkörper mit hohem Etofibrat-Gehalt und kontrollierter Wirkstoff-Freisetzung, deren Verwendung und daraus bestehende oral verabreichbare Applikationsformen
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
WO1993007859A1 (en) * 1991-10-23 1993-04-29 Warner-Lambert Company Novel pharmaceutical pellets and process for their production
DK0641195T3 (da) * 1992-05-22 1996-08-05 Goedecke Ag Fremgangsmåde til fremstilling af lægemiddelblandinger med forsinket virkning
CA2147283C (en) * 1992-10-16 2007-01-16 Kouichi Nakamichi Method of manufacturing wax matrices
ES2061394B1 (es) * 1993-02-05 1995-06-16 Robert S A Lab Procedimiento de fabricacion de un granulado de citrato potasico con cesion retardada.
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
US5843347A (en) * 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
FR2710500B1 (fr) * 1993-09-27 1995-12-01 Virbac Laboratoires Composition et système à administration orale pour animaux, leur procédé de préparation et leurs applications.
DE4422881A1 (de) * 1993-10-25 1995-04-27 Bayer Ag Kolloidal dispergierbare Wirkstoff-Formulierungen
ES2199981T3 (es) * 1994-02-16 2004-03-01 Abbott Laboratories Modo de preparacion de formulaciones farmaceuticas de particulas finas.
DE4413350A1 (de) * 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE29502547U1 (de) * 1995-02-16 1995-03-30 Roehm Gmbh Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
DE19531277A1 (de) 1995-08-25 1997-02-27 Basf Ag Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
DE19539363A1 (de) * 1995-10-23 1997-04-24 Basf Ag Verfahren zur Herstellung von festen Arzneiformen
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
DE10029201A1 (de) 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
CN1446119A (zh) 2000-08-03 2003-10-01 宝洁公司 生产颗粒组分的方法和设备
WO2018140941A1 (en) * 2017-01-30 2018-08-02 Case Western Reserve University Polymer constructs for controlled release of guest agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US3247065A (en) * 1963-10-14 1966-04-19 Hoffmann La Roche Free-flowing coated ascorbic acid
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
DE3024416C2 (de) * 1980-06-28 1982-04-15 Gödecke AG, 1000 Berlin Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
FR2515035A1 (fr) * 1981-10-26 1983-04-29 Rhone Poulenc Sante Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
EP0204596A1 (fr) 1986-12-10
DE3664867D1 (en) 1989-09-14
KR860008774A (ko) 1986-12-18
AU579012B2 (en) 1988-11-10
ES554821A0 (es) 1988-04-16
FI861923A (fi) 1986-11-10
FR2581541A1 (fr) 1986-11-14
ZA863431B (en) 1986-12-30
ATE45283T1 (de) 1989-08-15
MA20670A1 (fr) 1986-12-31
FI861923A0 (fi) 1986-05-08
EP0204596B1 (fr) 1989-08-09
CA1266841A (fr) 1990-03-20
FR2581541B1 (fr) 1988-05-20
ES8802206A1 (es) 1988-04-16
DK217286A (da) 1986-11-10
NZ216082A (en) 1989-01-06
AU5722486A (en) 1986-11-13
JPS61260029A (ja) 1986-11-18

Similar Documents

Publication Publication Date Title
DK217286A (da) Materialer til fremstilling af mikropartikler indeholdende et biologisk aktivt stof
DK0544144T3 (da) Fast farmaceutisk retardform
FI884604A (fi) Implanterbar, biologiskt nedbrytbart aktivmedels frigivningssystem.
ES2093621T3 (es) Polialquil-1-oxa-diaza-espirodecanos polimeros.
ATE13545T1 (de) Stabilisatorzusammensetzungen, halogenhaltige polymerzusammensetzungen, welche diese enthalten, und geformte gegenstaende, welche die polymerzusammensetzungen enthalten.
PT89055A (pt) Processo para a preparacao de um sistema de administracao de libertacao sustida para bloqueadores de canal de calcio a base de di-hidropiridinas substituidas
ES2039377T3 (es) Un supositorio.
ES2054268T3 (es) Aditivos polimericos.
ATE135696T1 (de) Diamino-s-triazinonderivate und diese enthaltende selbstlöschende polymere zusammensetzungen
FR2359171A1 (fr) Nouvelles compositions ignifugeantes a base d'esters du phosphore et d'ethers d'halogenoalkyle et d'aryle
BR9000009A (pt) Composicao estabilizada a base de 3-isotiazolonas
ATE181506T1 (de) Pharmazeutische präparate enthaltend polymere mit alkyl- oder heteroalkylhauptketten
IT1248073B (it) Composti polimerici, contenenti gruppi amminici ingombrati stericamente, adatti come stabilizzanti e composizioni polimeriche comprendenti gli stessi.
IT1237994B (it) Composizione stabilizzante per polimeri del vinilcloruro e composizioni polimeriche contenenti la stessa
ES2121070T3 (es) 3,9-bis(dialquilamino)-2,4,8,10-tetraoxa-3,9-difosfaespiro(5,5)-undecanos y composiciones estabilizadas.
FR2605223B1 (fr) Compositions therapeutiques stables a base d' huile vegetale hydrophobe et son procede de preparation
DE69004857D1 (de) Stereoreguläre Acrylonitril-Polymere und diese enthaltende Zusammensetzungen.
ES2062072T3 (es) Clorofibras con un caracter antiseptico permanente y procedimiento para obtenerlas.
ITMI911660A1 (it) Composti polimerici, contenenti gruppi amminici ingombrati stericamente, adatti come stabilizzanti e composizioni polimeriche comprendenti gli stessi.
IT8722451A0 (it) Composizione ritardante di fiamma per materiali polimerici in particolare poliolefinici e materiali polimerici autoestinguenti cosi' ottenuti.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment